Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years

Kidney International

Volumn 59, Issue 6, 2001, Pages 2346-2356

  Bosmans, Jean Louis ^a,b   Holvoet, Paul ^a,b   Dauwe, Simonne E H ^a,b   Ysebaert, Dirk K ^a,b   Chapelle, Thierry ^a,b   Jürgens, Angelika ^a,b   Kovacic, Vera ^a,b   Van Marck, Eric A ^a,b   De Broe, Marc E ^a,b   Verpooten, Gert A ^a,b,c  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Chronic allograft nephropathy; End stage renal disease; High density lipoprotein; Kidney graft; Oxidized LDL; Transplantation

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CREATININE CLEARANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 0034999681     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590062346.x     Document Type: Article

References (65)

1. Markell MS, Armenti V, Danovitch G, Sumrani N: Hyperlipidemia and glucose intolerance in the post-renal transplant patient. J Am Soc Nephrol 4:S37-S47, 1994
2. Divakar D, Bailey RR, Frampton CM, et al: Hyperlipidemia in stable renal transplant recipients. Nephron 59:423-428, 1991
3. Swan SK: Role of lipids in chronic renal allograft rejection, in Lipids and the Kidney Contributions to Nephrology (vol 120), edited by Keane WF, Hörl WH, Kasiske BL, Basel S, Karger AG, 1997, pp 62-67
4. Ghanem H, Van Den Dorpel MA, Weimar W, et al: Increased low density lipoprotein oxidation in stable kidney transplant recipients. Kidney Int 49:488-493, 1996
5. Sutherland WHF, Walker RJ, Ball MJ, et al: Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int 48:227-236, 1995
6. Taylor JE, Scott N, Hill A, et al: Oxygen free radicals and platelet and granulocyte aggregability in renal transplant patients. Transplantation 55:500-504, 1993
7. Wanner C, Greiber S, Krämer-Guth A, et al: Lipids and progression of renal disease: Role of modified low density lipoprotein (a). Kidney Int 52(Suppl 63):S102-S106, 1997
8. Keane WF, O'Donnell MP, Kasiske BL, Kim Y: Oxidative modification of low-density lipoproteins by mesangial cells. J Am Soc Nephrol 4:187-194, 1993
9. Magil AB, Fröhlich JJ, Innis SM, Steinbrecher UP: Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. Kidney Int 43:1243-1250, 1993
10. Pai R, Kirschenbaum MA, Kamanna VS: Low-density lipoprotein stimulates the expression of macrophage colony-stimulating factor in glomerular mesangial cells. Kidney Int 48:1254-1262, 1995
11. Kamanna VS, Pai R, Roh DD, Kirschenbaum MA: Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation. Lab Invest 74:1067-1079, 1996
12. Kamanna VS, Pai R, Ha H, et al: Oxidized low-density lipoprotein stimulates monocyte adhesion to glomerular endothelial cells. Kidney Int 55:2192-2202, 1999
13. Ong ACM, Moorhead JF: Tubular lipidosis: Epiphenomenon or pathogenetic lesion in human renal disease? Kidney Int 45:753-762, 1994
14. Agarwal A, Balla J, Balla G, et al: Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol 271:F814-F823, 1996
15. Gröne H-J, Hohbach J, Gröne EF: Modulation of glomerular sclerosis and interstitial fibrosis by native and modified lipoproteins. Kidney Int 49(Suppl 54):S18-S22, 1996
16. Roh DD, Kamanna VS, Kirschenbaum MA: Atherogenic lipoproteins enhance murine cortical epithelial cell fibronectin protein synthesis and gene expression. Am J Nephrol 18:83-88, 1998
17. Lee HS, Jeong JY, Kim BC, et al: Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Kidney Int 51:1151-1159, 1997
18. 2 and renin release in juxtaglomerular cells. Kidney Int 51:253-260, 1997
19. Kasiske BL: Role of circulating lipid abnormalities in chronic renal allograft rejection. Kidney Int 56(Suppl 71):S28-S30, 1999
20. Holvoet P: Oxidative modification of low-density lipoproteins in atherothrombosis. Acta Cardiol 53:253-260, 1998
21. Bosmans JL, Woestenburg AT, Ysebaert DK, et al: Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts. Transplantation 69:2388-2394, 2000
22. Racusen LC, Solez KM, Colvin RB, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713-723, 1999
23. Woestenburg AT, Mensch P, Bosmans JL, et al: Morphometric analysis of renal vessels: The advantage of multi-sector area approach of cross-sections. Anal Quant Cytol Histol 22:285-291, 2000
24. Holvoet P, Perez G, Zhao Z, et al: Malondialdehyde-modified low-density lipoproteins in patients with atherosclerotic disease. J Clin Invest 95:2611-2619, 1995
25. Holvoet P, Donck J, Landeloos M, et al: Correlation between oxidized low-density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost 76:663-669, 1996
26. Nouwen EJ, Pollet DE, Eerdekens MW, et al: Immunohistochemical localisation of placental alkaline phosphatase, carcinoembryogenic antigen, and cancer antigen 125 in normal and neoplastic human lung. Cancer Res 46:866-876, 1986
27. Dimény E, Tufveson G, Lithell H, et al: The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation. Eur J Clin Invest 23:572-579, 1993
28. Isoniemi H, Nurminen M, Tikkanen MJ, et al: Risk factors predicting chronic rejection of renal allografts. Transplantation 57:68-72, 1994
29. Guijarro C, Massy ZA, Kasiske BL: Clinical correlation between renal allograft failure and hyperlipidemia. Kidney Int 48(Suppl 52):S56-S59, 1995
30. Halloran PF, Melk A, Barth C: Rethinking chronic allograft nephropathy: The concept of accelerated senescence. J Am Soc Nephrol 10:167-181, 1999
31. Kamanna VS, Roh DD, Kirschenbaum MA: Hyperlipidemia and kidney disease: Concepts derived from histopathology and cell biology of the glomerulus. Histol Histopathol 13:169-179, 1998
32. Cosio FG, Pelletier RP, Falkenhain ME, et al: Impact of acute rejection and early allograft function on renal allograft survival. Transplantation 63:1611-1615, 1997
33. Lindholm A, Ohman S, Albrechtsen D, et al: The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 56:307-315, 1993
34. Matas AJ, Gillingham KJ, Humar A, et al: Immunologic and nonimmunologic risk factors: Different risks for cadaver and living donor transplantation. Transplantation 69:54-58, 2000
35. Hariharan S, Johnson CP, Bresnahan BA, et al: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605-612, 2000
36. Syrjänen J, Mustonen J, Pasternack A: Hypertriglyceridaemia and hyperuricemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 15:34-42, 2000
37. Samuelsson O, Attman P-O, Knight-Gibson C, et al: Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol 9:1482-1488, 1998
38. Modification of Diet in Renal Disease Study Group: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51:1908-1919, 1997
39. Muntner P, Coresh J, Clinton Smith J, et al: Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study. Kidney Int 58:293-301, 2000
40. Joles JA, Van Goor H, Van Der Horst MLC, et al: Ovariectomy decreases plasma triglyceride levels and both prevents and alleviates glomerular disease in uninephrectomized female analbuminemic rats. J Am Soc Nephrol 7:1189-1197, 1996
41. De Lorgeril M, Boissonat P, Mamelle N, et al: Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients. Circulation 89:2590-2594, 1994
42. Holvoet P, Van Cleemput J, Collen D, Vanhaecke J: Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 20: 698-702, 2000
43. Ross R: Atherosclerosis: An inflammatory disease. N Engl J Med 340:115-126, 1999
44. Holvoet P, Collen D: Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J 8:1279-1284, 1994
45. Hattori M, Ito K, Kawaguchi H, Yamaguchi Y: Probucol reduces renal injury in the ExHC rat. Nephron 67:459-468, 1994
46. Parthasarathy S, Barnett J, Fong LG: High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochem Biophys Acta 1044:275-283, 1990
47. Huang J-M, Huang Z-X, Zhu W: Mechanism of high-density lipoprotein subfractions inhibiting copper-catalyzed oxidation of low-density lipoprotein. Clin Biochem 31:537-543, 1998
48. Holvoet P, Collen D: Oxidation of low-density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis 137:S33-S38, 1998
49. Mackness MI, Durrington PN, Mackness B: How high-density lipoprotein protect against the effects of lipidperoxidation. Curr Opin Lipidol 11:383-388, 2000
50. Mackness MI, Abbott CA, Arrol S, Durrington PN: The role of high density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 294:829-835, 1993
51. Watson AD, Navab M, Hama SY, et al: Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low-density lipoprotein. J Clin Invest 95:774-782, 1995
52. Bowry VW, Stanley KK, Stocker R: High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci USA 89:10316-10320, 1992
53. Nagase M, Kaname S, Nagase T, et al: Expression of LOX-1, an oxidized low-density lipoprotein receptor, in experimental hypertensive glomerulosclerosis. J Am Soc Nephrol 11:1826-1836, 2000
54. Austin MA, King MC, Vranizan KM, Krauss RM: Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 82:495-506, 1990
55. Austin MA, Breslow JL, Hennekens CH, et al: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921, 1988
56. Degraaf J, Hak-Lemmers HL, Hectors MC, et al: Enhanced susceptibility to in vitro oxidation of the dense low-density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 11:298-306, 1991
57. Chait A, Brazg RL, Tribble DL, Krauss RM: Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, Pattern B. Am J Med 94:350-356, 1993
58. Quinn MT, Parthasarathy S, Fong LG, Steinberg D: Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 84:2995-2998, 1987
59. Rajavashisth TB, Andalibi A, Territo MC: Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified lipoproteins. Nature 344:254-257, 1990
60. Leonard EJ, Yoshimura T: Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11:97-101, 1990
61. Nikolic-Paterson DJ, Lan HY, Hill PA, Atkins RC: Macrophages in renal injury. Kidney Int 45(Suppl 45):S79-S82, 1994
62. Eddy AA: Interstitial macrophages as mediators of renal fibrosis. Exp Nephrol 3:76-79, 1995
63. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495-2508, 1996
64. Duymelinck C, Dauwe SHE, De Greef KEJ, et al: TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat. Kidney Int 58:1186-1201, 2000
65. Poirier B, Lannaud-Bournoville M, Conti M, et al: Oxidative stress occurs in absence of hyperglycemia and inflammation in the onset of kidney lesions in normotensive obese rats. Nephrol Dial Transplant 15:467-476, 2000